Dr. Nathan D. McLaughlin, MD

Dr. McLaughlin practices at Riverside University Medical Center in Moreno Valley, California.

Dr. McLaughlin's NPI, 1104069889, was assigned on April 11, 2009. Dr. McLaughlin graduated from VCU School of Medicine in 2009. Dr. McLaughlin holds California license A125742.

Dr. McLaughlin's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. McLaughlin's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. McLaughlin is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Indio Community Health Center. Dmand AI also links Dr. McLaughlin to 1 more community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. McLaughlin is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. McLaughlin's licenses on file in 2 states: California and Illinois.

Dmand AI lists chronic diabetes, chronic hypertension, heart failure, insomnia, osteoporosis, sepsis, syncope & collapse and upper respiratory infection (URI) among the conditions Dr. McLaughlin treats.

CMS data shows 55 Medicare services from Dr. McLaughlin across 2 procedure codes in 2024, for 26 Medicare patients. Medicare paid $4,478 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. McLaughlin in 2024. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 53, with 63% women.

In 2024, Dr. McLaughlin wrote 435 Medicare Part D claims for 118 patients. 85% of them were for generic drugs. CMS names the drug for 171 of them, across 9 drugs with 11 or more claims each, at $2,433 in total drug cost. In 2023, CMS named 173 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McLaughlin for performance year 2024, reported as part of a group.

Dmand AI links 5 papers to Dr. McLaughlin, published from 2010 to 2017. The most frequent topics are Lung, Endothelial Cells and Neutrophils. Dr. McLaughlin's most frequent co-authors are Anirban Banerjee, MD, Christopher Silliman, MD and John C. Eun, MD.

Dr. McLaughlin graduated from VCU School of Medicine in 2009.

Dr. McLaughlin is in network with 3 carriers, including CMS Medicare, Humana and Molina. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.